Literature DB >> 25728824

Evaluation of topical hesperetin matrix film for back-of-the-eye delivery.

Goutham R Adelli1, Tushar Hingorani1, Nagendra Punyamurthula1, Sai Prachetan Balguri1, Soumyajit Majumdar2.   

Abstract

PURPOSE: The goal of the present study was to develop a poly (ethylene oxide) N10 (PEO N10) based melt-cast matrix system for efficient and prolonged delivery of hesperetin (HT), a promising bioflavonoid, to the posterior segment of the eye through the topical route.
METHODS: HT film was prepared by melt-cast method using PEO N10 and cut into 4mm×2mm segments, each weighing 8mg. This film was evaluated with respect to in vitro release rates and also transmembrane delivery across Spectra/Por® membrane (MWCO: 10,000 Daltons) and isolated rabbit corneas. Ocular tissue concentrations were also determined postapplication of the film in ex vivo and in vivo models.
RESULTS: HT release from the film was determined to be about 95.3% within 2h. In vitro transcorneal flux was observed to be 0.58±0.05μg/min/cm(2) across the isolated rabbit cornea. High levels of HT were detected in the retina-choroid (RC) and vitreous humor (VH) in the ex vivo model following topical application of the film. Significant levels of HT were observed in both anterior and posterior segment ocular tissues 1h post topical application of the 10 and 20%w/w HT films on the rabbit eye. Moreover, HT was detected in the VH and RC even after 6h following topical application of the film in vivo.
CONCLUSION: The results from this study suggest that the melt-cast films can serve as a viable platform for sustained topical delivery of bioflavonoids, and other therapeutic agents, into the back-of-the eye tissues.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Back-of-the eye delivery; Bioflavonoids; Hesperetin; Hot melt extrusion; Melt-cast technology; Polyethylene oxide; Polymeric matrix film; Sustained delivery; Topical application

Mesh:

Substances:

Year:  2015        PMID: 25728824      PMCID: PMC4430415          DOI: 10.1016/j.ejpb.2015.02.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  40 in total

Review 1.  Drug delivery for posterior segment eye disease.

Authors:  D H Geroski; H F Edelhauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

2.  Qualitative analysis of telehomecare nursing activities.

Authors:  Kathryn H Dansky; Brye Yant; Donna Jenkins; Cheryl Dellasega
Journal:  J Nurs Adm       Date:  2003 Jul-Aug       Impact factor: 1.737

3.  Normal human tear pH by direct measurement.

Authors:  M B Abelson; I J Udell; J H Weston
Journal:  Arch Ophthalmol       Date:  1981-02

4.  Diabetic complications: retinopathy.

Authors:  P J Watkins
Journal:  Br Med J (Clin Res Ed)       Date:  1982-08-07

5.  Modulation of peroxynitrite-induced fibroblast injury by hesperetin: a role for intracellular scavenging and modulation of ERK signalling.

Authors:  Susan E Pollard; Matthew Whiteman; Jeremy P E Spencer
Journal:  Biochem Biophys Res Commun       Date:  2006-07-05       Impact factor: 3.575

6.  Intravitreal kinetics of hesperidin, hesperetin, and hesperidin G: effect of dose and physicochemical properties.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2012-01-06       Impact factor: 3.534

7.  Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid.

Authors:  Soumyajit Majumdar; Ramesh Srirangam
Journal:  Pharm Res       Date:  2008-09-23       Impact factor: 4.200

8.  Exploring the effect of Hesperetin-HSPC complex--a novel drug delivery system on the in vitro release, therapeutic efficacy and pharmacokinetics.

Authors:  Kuntal Maiti; Kakali Mukherjee; Venkatesh Murugan; Bishnu Pada Saha; Pulok Kumar Mukherjee
Journal:  AAPS PharmSciTech       Date:  2009-07-24       Impact factor: 3.246

9.  Flavonoids and nitric oxide synthase.

Authors:  R Olszanecki; A Gebska; V I Kozlovski; R J Gryglewski
Journal:  J Physiol Pharmacol       Date:  2002-12       Impact factor: 3.011

10.  Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2012-07-13       Impact factor: 2.671

View more
  6 in total

1.  Melt-Cast Noninvasive Ocular Inserts for Posterior Segment Drug Delivery.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Akshaya Tatke; Karthik Yadav Janga; Prakash Bhagav; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2017-08-01       Impact factor: 3.534

2.  Ocular disposition of ciprofloxacin from topical, PEGylated nanostructured lipid carriers: Effect of molecular weight and density of poly (ethylene) glycol.

Authors:  Sai Prachetan Balguri; Goutham R Adelli; Karthik Yadav Janga; Prakash Bhagav; Soumyajit Majumdar
Journal:  Int J Pharm       Date:  2017-06-17       Impact factor: 5.875

3.  Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery.

Authors:  Goutham R Adelli; Sai Prachetan Balguri; Prakash Bhagav; Vijayasankar Raman; Soumyajit Majumdar
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Hesperetin-loaded lipid-core nanocapsules in polyamide: a new textile formulation for topical drug delivery.

Authors:  Paula Dos Passos Menezes; Luiza Abrahão Frank; Bruno Dos Santos Lima; Yasmim Maria Barbosa Gomes de Carvalho; Mairim Russo Serafini; Lucindo José Quintans-Júnior; Adriana Raffin Pohlmann; Sílvia Stanisçuaski Guterres; Adriano Antunes de Souza Araújo
Journal:  Int J Nanomedicine       Date:  2017-03-15

5.  Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.

Authors:  Goutham R Adelli; Prakash Bhagav; Pranjal Taskar; Tushar Hingorani; Sara Pettaway; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-04-01       Impact factor: 4.799

6.  Melt-Cast Films Significantly Enhance Triamcinolone Acetonide Delivery to the Deeper Ocular Tissues.

Authors:  Akshaya Tatke; Narendar Dudhipala; Karthik Yadav Janga; Bhavik Soneta; Bharathi Avula; Soumyajit Majumdar
Journal:  Pharmaceutics       Date:  2019-04-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.